CMS Open Payments · Tool
Blustone Synergy, LLC vs Progenics Pharmaceuticals, Inc.
Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.
A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.
Compare Different Companies
Payment Overview
Blustone Synergy, LLC
- Total Payments
- $4.9M
- % of Industry
- 0.0%
- Transactions
- 1
- Avg per Transaction
- $4.9M
- Recipients
- 0
- Avg per Recipient
- $0.00
- Payment Types
- 0
- Top Payment Type
- -
Progenics Pharmaceuticals, Inc.
- Total Payments
- $4.8M
- % of Industry
- 0.0%
- Transactions
- 6,742
- Avg per Transaction
- $708.49
- Recipients
- 6,457
- Avg per Recipient
- $739.76
- Payment Types
- 5
- Top Payment Type
- Compensation for Services Other Than Consulting
Highlighted values indicate the higher figure for each metric.
Total payments compared
Blustone Synergy, LLC vs Progenics Pharmaceuticals, Inc. - total reported payments in CMS Open Payments PY2024
General Payment Types Breakdown
Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.
Blustone Synergy, LLC
No payment type data available.
Progenics Pharmaceuticals, Inc.
49.5%
30.4%
11.7%
7.9%
0.6%
Top 5 General-Payment Recipients
This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.
Blustone Synergy, LLC
No recipient data available.
Progenics Pharmaceuticals, Inc.
- 1
APRIL HARLYNN TEITELBAUM
$383,599.11 · 29 txns
- 2
EDWARD OBEDIAN
$111,593.95 · 89 txns
- 3
GIUSEPPE ESPOSITO
$108,296.72 · 75 txns
- 4
GARY ALLAN ULANER
$105,006.11 · 85 txns
- 5
STEVEN PATRICK ROWE
$103,063.02 · 66 txns
Summary Comparison
| Metric | Blustone Synergy, LLC | Progenics Pharmaceuticals, Inc. |
|---|---|---|
| Total Payments | $4.9M | $4.8M |
| % of Industry Total | 0.0% | 0.0% |
| Transaction Count | 1 | 6,742 |
| Avg per Transaction | $4.9M | $708.49 |
| Recipient Count | 0 | 6,457 |
| Avg per Recipient | $0.00 | $739.76 |
| Payment Type Count | 0 | 5 |
| Top Payment Type | - | Compensation for Services Other Than Consulting |
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.